Antengene Corporation Limited announced the appointment of Kevin Lynch, M.D. as Chief Medical Officer (CMO) of Antengene. In this position, Kevin will be responsible for the strategy, direction, and execution of the company's clinical development plans and will directly report to Dr. Jay Mei, Founder, Chairman and CEO of Antengene. Kevin has almost 30 years of experience in R&D in the pharmaceutical industry. He has experience in multiple national, regional and global clinical roles, building organizations across Clinical Development and Medical Affairs previously at Novartis and Celgene. At Celgene, he was Vice President leading the European Clinical Development program before his most recent role in Asia-Pacific as Vice President and Head of Clinical Development and Medical Affairs.